Quick Answer
BIOGEN INC. reported Operating Income of $2.84 billion for fiscal year 2021.
BIOGEN INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2021 | $2.84B | -37.6% |
| 2020 | $4.55B | -35.4% |
| 2019 | $7.04B | +19.6% |
| 2018 | $5.89B | +10.2% |
| 2017 | $5.35B | +3.8% |
| 2016 | $5.15B | +5.3% |
| 2015 | $4.89B | +23.1% |
| 2014 | $3.97B | +57.9% |
| 2013 | $2.52B | +35.5% |
| 2012 | $1.86B | +7.6% |
| 2011 | $1.72B | +38.1% |
| 2010 | $1.25B | -3.6% |
| 2009 | $1.30B | +6.7% |
| 2008 | $1.21B | +55.6% |
| 2007 | $779.77M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $610.70M | -37.3% | -23.1% |
| September 30, 2021 | $794.00M | -26.9% | +63.5% |
| June 30, 2021 | $485.70M | -75.4% | -50.1% |
| March 31, 2021 | $973.90M | -46.5% | -10.4% |
| September 30, 2020 | $1.09B | -39.9% | -45.0% |
| June 30, 2020 | $1.97B | +1.0% | +8.5% |
| March 31, 2020 | $1.82B | +21.1% | +0.8% |
| September 30, 2019 | $1.81B | +6.4% | -7.6% |
- BIOGEN INC. showed a decrease of -37.6% in Operating Income compared to the prior fiscal year.
- Over the 2007–2021 period, BIOGEN INC.’s operating income has grown by 264.3% (from $779.77 million to $2.84 billion).
- The most recent figure is from BIOGEN INC.’s fiscal year 2021 report (Form 10-K), filed with the SEC on February 3, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: